In 2015, the pharmaceutical company won approval for its GC Flu Quadrivalent, the first is Asia and the fourth worldwide flu vaccine that covers four strains of influenza -- two influenza A strains (H1N1, H3N2) and two influenza B strains (Yamagata, Victoria) -- with a single vaccination.
Green Cross currently exports trivalent flu vaccine to 30 countries but has not been able to enter the US, the largest flu vaccine market with US$1.6 billion sales volume.
|Green Cross's Hwasun plant in South Korea|
If granted permission, it will be the first South Korean flu vaccine to be sold in the US.
By Hwang You-mee (email@example.com)